At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- The colonoscopy reimbursement math is not adding up (Becker’s Healthcare)
- Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey (Fierce Healthcare)
- Microbiome Testing Needs Its Standards Moment (Op-Med)
- Combined GI Endoscopy Has a Quality Assurance Gap. At Current Volume, That Gap Has Institutional Consequences. (HIT Consultant)
- Computer-aided polyp detection multicenter international randomized controlled study with a focus on community clinics: Gastroenterology Artificial INtelligence system for detecting colorectal polyps (ScienceDirect)
- Researchers Analyzing Colon Cancer Screenings Find Hope for Higher Retest Rates (Rutgers)
- Exclusive: Co-Founded By Former Whoop CTO, Throne Science Raises $10M To Track Gut Health From The Toilet (Crunchbase)
- GI Societies Oppose Proposed Federal Rule That Would Reshape Biomedical Research (American College of Gastroenterology)
